Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Use of Distal Radial Access for Recanalization of Radial Occlusions

Transradial access (TRA) is the preferred route for most percutaneous coronary procedures, with proven benefits in reducing vascular complications and shortening recovery time. However, despite its safety, it is not exempt from complications, such as radial artery occlusion (RAO). 

Although clinically silent in most cases due to collateral circulation of the wrist and hand, RAO represents a significant limitation for repeat procedures, its use in bypass grafts for surgical revascularization, or the creation of hemodialysis access.

To address this challenge, distal radial access (DRA), performed at the anatomical snuffbox, has emerged as a safe and effective alternative—not only to reduce the incidence of RAO but also to enable retrograde recanalization of previously occluded arteries.

Colletti et al. published an international multicenter study analyzing, retrospectively, a cohort of 110 patients with RAO treated across seven international centers by operators with experience exceeding 200 DRA cases. The mean age was 66 years, and 60% were male. The strategy followed a structured approach, with techniques adapted to the morphology of the distal cap (tapered or blunt), employing drilling or knuckling methods to cross the occlusion, followed by dilatation with dotterization or, in selected cases, balloon angioplasty.

Dotterization (dilation of the segment using the introducer sheath or guiding catheters) was performed in 62% of cases, while balloon angioplasty was used in the remaining 38%. Conversion to sheathless catheters was reported in 47% of patients.

Read also: Is the Acceleration Time/Ejection Time Ratio Superior to the Mean Gradient in Predicting Clinical Outcomes After TAVR?

The procedure achieved a technical success rate of 94% and a 30-day radial patency rate of 80%, with a low incidence of acute complications (4.5%: 4 radial perforations and 1 EASY III hematoma), all resolved conservatively. One of the most relevant findings of the multivariate analysis was the identification of the sheathless approach as an independent predictor of 30-day patency (OR 3.07; 95% CI: 1.10–8.59). Conversely, the use of sheaths larger than 6F (OR 0.15) and balloons over 2.25 mm (OR 0.10) was associated with lower patency rates.

Conclusions

This study reaffirms the value of DRA not only as a primary access route but also as a therapeutic tool for radial recanalization, consolidating its role within the modern interventional cardiology toolkit. The implementation of a standardized approach, with special emphasis on less invasive techniques such as sheathless use, could optimize patency outcomes and reduce the need for alternative access routes.

Original Title: Distal Radial Access for Radial Artery Recanalization Multicenter Outcomes and Stepwise Strategies to Maximize Patency.

Reference: Colletti G, Sgueglia GA, Gasparini GL, Ungureanu C, Tsigkas G, Leibundgut G, Cocoi M, Gach O, Boukhris M, Novotný V, Cocco N, Peter L, Natalis A, Novelli L, Benthakhou E, Kákonyi K, Tumscitz C, Achim A, Rusza Z. Distal Radial Access for Radial Artery Recanalization: Multicenter Outcomes and Stepwise Strategies to Maximize Patency. JACC Cardiovasc Interv. 2025 Sep 8;18(17):2140-2151. doi: 10.1016/j.jcin.2025.07.003. PMID: 40930602.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

Dr. Omar Tupayachi
Dr. Omar Tupayachi
Member of the Editorial Board of solaci.org

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...